News about "Aurobindo Pharma"

CuraTeQ Biologics Secures UK MHRA Approval for Bevqolva

Bevqolva 25 mg/mL concentrate for infusion will be available in 4 mL (100 mg) and 16 mL (400 mg) single-use vials for infusion into veins.

Aurobindo Pharma | 23/12/2024 | By Aishwarya

Eugia Pharma Gets FDA Approval for Pazopanib Tablets

Aurobindo Pharma has announced that its wholly owned subsidiary company, Eugia Pharma Specialities, has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Pazopanib Tablets, 200 mg.

Aurobindo Pharma | 06/12/2024 | By Aishwarya

Six Pharma Firms Plans to Build Green Pharma Units in Telangana

As per the MoUs, the MSN Group will establish a manufacturing unit and an R&D centre and Aurobindo Pharma and Laurus Labs will set up formulation units.

Aurobindo Pharma | 25/11/2024 | By Aishwarya |  104

Aurobindo to Fully Acquire GLS Pharma for INR 22.5 Crore

The company entered into a binding agreement with GLS Pharma Ltd. and its promoters for the acquisition of the remaining 5,90,361 equity shares of INR 10 each amounting to a 49 percent stake for a purchase consideration of INR 22.5 crore.

Aurobindo Pharma | 19/09/2024 | By Aishwarya

TheraNym Signs MSA with MSD for Biologics Manufacturing

Aurobindo Pharma has announced that its wholly owned subsidiary, TheraNym Biologics Private Ltd., has signed a Master Service Agreement (MSA) with Merck Sharpe & Dohme Singapore Trading (MSD).
<br />

Aurobindo Pharma | 01/06/2024 | By Aishwarya |  667

Aurobindo Pharma Appoints T. Vijaya Kumar as President, R&D

Aurobindo Pharma has announced the appointment of T. Vijaya Kumar as President, R&D (Specialty Drug Delivery).

Aurobindo Pharma | 08/04/2024 | By Aishwarya |  613

Aurobindo Pharma Ltd gets 3 observations from USFDA for Unit 3 at Bachupally Village

Aurobindo Pharma Ltd gets 3 observations from USFDA for Unit 3 at Bachupally Village

Aurobindo Pharma | 24/07/2023 | By Sudeep Soparkar |  1390

US FDA Inspection at Aurobindo Pharma Ltd's Unit XIV, Anakapalli District, Andhra Pradesh

US FDA Inspection at Aurobindo Pharma Ltd's Unit XIV, Anakapalli District, Andhra Pradesh

Aurobindo Pharma | 18/07/2023 | By Sudeep Soparkar |  221

Aurobindo Pharma arm in Puerto Rico to halt production for expansion works

Aurobindo Pharma’s wholly owned step-down subsidiary in Puerto Rico, Auro PR Inc., will halt manufacturing to facilitate a restructuring of its facility from next month.

Aurobindo Pharma | 06/07/2023 | By Sudeep Soparkar |  517

Aurobindo Pharma Ltd's subsidiary to withdraw application for EU Marketing Authorization of two biosimilars

Aurobindo Pharma Ltd's subsidiary to withdraw application for EU Marketing Authorization of two biosimilars

Aurobindo Pharma | 26/06/2023 | By Sudeep Soparkar |  450